This article entitled “Intracoronary Adenosine versus Intravenous Adenosine during Primary PCI for ST-Elevation Myocardial Infarction: Which One Offers Better Outcomes in terms of Microvascular Obstruction?” [1], published in ISRN Cardiology, has been retracted upon the authors’ request, as it was found to include erroneous data that their findings and conclusions cannot be relied upon. Additionally, the article was submitted for publication by the author Gemina Doolub without the knowledge and approval of the other author Erica Dall’Armellina.
Retraction | Open Access
Retracted: Intracoronary Adenosine versus Intravenous Adenosine during Primary PCI for ST-Elevation Myocardial Infarction: Which One Offers Better Outcomes in terms of Microvascular Obstruction?
Received19 Nov 2013
Accepted19 Nov 2013
Published14 Dec 2013
References
G. Doolub and E. Dall'Armellina, “Intracoronary adenosine versus intravenous adenosine during primary PCI for ST-elevation myocardial infarction: which one offers better outcomes in terms of microvascular obstruction?” ISRN Cardiology, vol. 2013, Article ID 248476, 8 pages, 2013.
View at: Publisher Site | Google Scholar
Copyright
Copyright © 2013 ISRN Cardiology. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.